Virility Medical has developed a clinically proven, FDA-cleared wearable device that utilizes muscle stimulation technology to enhance pelvic-floor muscle control, effectively delaying ejaculation. This drug-free, discreet skin patch provides immediate results, promoting sexual spontaneity for men experiencing premature ejaculation.
Funding
$19.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MIFounders
Product
Problem
Premature ejaculation affects a significant portion of the male population, leading to decreased sexual satisfaction and emotional distress. Current treatments often involve medication with potential side effects or behavioral therapies that require consistent effort and may not provide immediate results.
Solution
Virility Medical offers a wearable, FDA-cleared device that utilizes muscle stimulation to enhance pelvic-floor muscle control, providing men with a drug-free solution for premature ejaculation. The discreet skin patch delivers immediate results, promoting sexual spontaneity by improving the user's ability to delay ejaculation through targeted muscle contractions. This technology offers a clinically proven alternative to traditional treatments, empowering men to take control of their sexual health and improve their overall well-being.
Target Audience
The primary target audience is men experiencing premature ejaculation who are seeking a drug-free, discreet, and effective solution to improve their sexual health and well-being.
Features
- Wearable skin patch for discreet application
- Clinically proven muscle stimulation technology
- Enhances pelvic-floor muscle control
- Drug-free solution for premature ejaculation
- Immediate effect promoting sexual spontaneity
- FDA-cleared for safety and efficacy
- CE-marked
- Disposable design for convenient use